A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation (NCT05485974)

🧪 Interventions in This Study

• HBI-2438 (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (14 Sites)

• California Cancer Associates for Research and Excellence, Inc. (cCare) — Encinitas, California
• The Oncology Institute of Hope and Innovation — Glendale, California
• The Oncology Institute of Hope and Innovation — Long Beach, California
• The Oncology Institute of Hope and Innovation — Pasadena, California
• California Cancer Associates for Research and Excellence, Inc. (cCare) — San Marcos, California
• The Oncology Institute of Hope and Innovation — Santa Ana, California
• Sarcoma Oncology — Santa Monica, California
• Innovative Clinical Research Institute (ICRI) — Whittier, California
• The Oncology Institute of Hope and Innovation — Whittier, California
• BRCR Medical Center — Plantation, Florida
• Michigan Center of Medical Research — Farmington Hills, Michigan
• Alliance for Multispecialty Research, LLC — Kansas City, Missouri
• Gabrail Cancer Center — Canton, Ohio
• Pan American Center for Oncology Trials (PanOncology Trials) — Rio Piedras, Puerto Rico

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Lung Cancer

• Implementation Strategies for Monitoring Adherence in Real Time — Philadelphia, Pennsylvania
• Early Detection of Lung Cancer — Nashville, Tennessee
• Improving Utilization of Lung Cancer Screening in Underserved PA Populations — Allentown, Pennsylvania
• Effect of Pulmonary Rehabilitation on Surgical Outcomes in the Cancer Setting — Houston, Texas
• Testing the Engaged Approach to Lung Cancer Screening — Denver, Colorado
• Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer — Boston, Massachusetts

Explore by condition: All Lung Cancer clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.